





























参考图片
Flow cytometric analysis of cleaved PARP (Asp 214) expression (left panel). Cells from the human Jurkat (ATCC TIB-152) cell line were cultured for 6 hours with (solid line histogram) or without (dashed line histogram) Camptothecin (Sigma-Aldrich Cat. No. C-9911; 12 μM final concentration). The cells were harvested, washed with BD Pharmingen™ Stain Buffer (FBS) (Cat. No. 554656), and fixed and permeabilized with BD Cytofix/Cytoperm™ Fixation and Permeabilization Solution (Cat. No. 554722). The cells were then washed and stained in BD Perm/Wash™ Buffer (Cat. No. 554723) with BD Horizon™ BV421 Mouse Anti-Cleaved PARP (Asp 214) antibody (Cat. No. 564129). Histograms were derived from gated events with the forward and side light-scatter characteristics of intact Jurkat cells. Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System. Immunofluorescent analysis of cleaved PARP in apoptotic human cells (right panel). HeLa cells (ATCC, CCL-2) were treated with camptothecin (20 µM, 6 hours) to induce apoptosis. Cells were then fixed with BD Cytofix™ Fixation Buffer (Cat. No. 554655), permeabilized with BD Phosflow™ Perm Buffer III (Cat. No. 558050), and blocked with 5% goat serum, 1% BSA, and 0.5% Triton™ X-100 diluted in PBS. Cells were stained with BD Horizon™ BV421 Mouse Anti-Cleaved PARP (Asp 214) antibody (Cat. No. 564129, pseudo-colored red) and Alexa Fluor® 488 Mouse Anti-GM130 antibody (Cat. No. 560257, pseudo-colored green). DRAQ5 was used as a nuclear counterstain (Cat. No. 564902/564903, pseudo-colored blue). Images were captured on a standard epifluorescence microscope. Original magnification, 20x.
Flow cytometric analysis of cleaved PARP (Asp 214) expression (left panel). Cells from the human Jurkat (ATCC TIB-152) cell line were cultured for 6 hours with (solid line histogram) or without (dashed line histogram) Camptothecin (Sigma-Aldrich Cat. No. C-9911; 12 μM final concentration). The cells were harvested, washed with BD Pharmingen™ Stain Buffer (FBS) (Cat. No. 554656), and fixed and permeabilized with BD Cytofix/Cytoperm™ Fixation and Permeabilization Solution (Cat. No. 554722). The cells were then washed and stained in BD Perm/Wash™ Buffer (Cat. No. 554723) with BD Horizon™ BV421 Mouse Anti-Cleaved PARP (Asp 214) antibody (Cat. No. 564129). Histograms were derived from gated events with the forward and side light-scatter characteristics of intact Jurkat cells. Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System. Immunofluorescent analysis of cleaved PARP in apoptotic human cells (right panel). HeLa cells (ATCC, CCL-2) were treated with camptothecin (20 µM, 6 hours) to induce apoptosis. Cells were then fixed with BD Cytofix™ Fixation Buffer (Cat. No. 554655), permeabilized with BD Phosflow™ Perm Buffer III (Cat. No. 558050), and blocked with 5% goat serum, 1% BSA, and 0.5% Triton™ X-100 diluted in PBS. Cells were stained with BD Horizon™ BV421 Mouse Anti-Cleaved PARP (Asp 214) antibody (Cat. No. 564129, pseudo-colored red) and Alexa Fluor® 488 Mouse Anti-GM130 antibody (Cat. No. 560257, pseudo-colored green). DRAQ5 was used as a nuclear counterstain (Cat. No. 564902/564903, pseudo-colored blue). Images were captured on a standard epifluorescence microscope. Original magnification, 20x.